Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03797482

A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer

Status
Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Tata Memorial Hospital · Other Government
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

To understand the effects induced by acute hypoxia that sets in during surgery in breast cancer. To study this, clinical samples (Tumor biopsies) will be obtained during the surgery after partial devascularisation (sample B) and stored for future genomic and proteonomic evaluations.

Detailed description

Three tumor samples will be obtained after the patient is under anaesthesia, 1. Prior to starting surgery (Sample A) 2. The middle intra-operative sample, which will be collected when half the tumour has been devascularized (i.e., somewhere midway during the surgery). (Sample B) 3. A third post excision (anoxic sample C). These tumour tissue samples will be stored as snap frozen, in RNA later and as paraffin sections. To understand the effects induced by acute hypoxia that sets in during surgery in breast cancer. To study this, clinical samples (Tumor biopsies) will be obtained during and stored for future genomic and proteonomic evaluations.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntra-operative Tumor Tissue BiopsyThe changing pattern of gene expression during surgery has never been studied. This could be an effect of acute hypoxia that sets in the tumour during surgery or could be a surgical response. To study these changes happening in the tumour during surgery, we are taking serial biopsies during surgery, one at the beginning, one midway during surgery and one at the end of surgery. These samples will be snap frozen and stored at -80 deg celsius in biorepository for future analysis.

Timeline

Start date
2017-11-27
Primary completion
2025-09-30
Completion
2025-11-30
First posted
2019-01-09
Last updated
2025-09-10

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT03797482. Inclusion in this directory is not an endorsement.